Statins and prostate cancer Endocrine Today, NJ - Nov 12, 2008 If that occurs, that would be another mechanism where statins could lower PSA and prostate cancer risk. Several other studies have investigated the effects ...
Drugs you can't have Stuff.co.nz, New Zealand - Nov 30, 2008 Here are a few of the good news stories: * Statins for heart disease: Around 300000 New Zealanders are now using cheap and effective anti- cholesterol drugs ...
High blood pressure during pregnancy Globe and Mail, Canada - Nov 7, 2008 But it's equally possible statins are producing misleading readings that could get in the way of an accurate diagnosis of cancer. ...
More good news about statins Drug Topics Magazine, NJ - Nov 14, 2008 The caveats: The effect of statins on the risk of prostate cancer was not determined in this study, and it is possible that lowered PSA levels resulting ...
Statins may disguise prostate cancer Healthcare Republic - Nov 6, 2008 'With lower PSA levels, physicians may be less likely to perceive patients to be at risk of prostate cancer and thus less likely to recommend a prostate ...
Recent News and Articles on the Keywords: cancer risk + risk + cancer Related to the article below (Last Update: 8/7/2008)
Exercise Lowers Risk of Colon Cancer U.S. News & World Report, DC - 6 (HealthDay News) -- Physical activity can reduce the risk of colon cancer, but few American adults are aware of this, a new study shows. ...
Sticking to diet advice cuts colon cancer risk Reuters - She and her colleagues looked at the relationship between diet pattern and colorectal cancer risk in 492382 men and women participating in the National ...
High Milk Intake May Boost Ovarian Cancer Risk Online - International News Network, Pakistan - ISLAMABAD: High intakes of whole milk and lactose might be associated with an increased risk of ovarian cancer, suggests a review of 21 published studies. ...
E. Hanover residents: Power line may risk our health Dailyrecord.com, NJ - "It's very obvious to me that there's not enough information on what we're worried about the most -- it's the cancer." Residents and council members took ...
Source: Google News
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study. - JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma … - The Journal of Urology, 1998 - jurology.com ... Plasma Insulin-Like Growth Factor-I and Prostate CancerRisk: A Prospective
Study. Chan ... Diabetes and the risk of prostate cancer. European ...
Soy intake and cancer risk: a review of the in vitro and in vivo data. - MJ Messina, V Persky, KD Setchell, S Barnes - Nutr Cancer, 1994 - ncbi.nlm.nih.gov Nutr Cancer. 1994;21(2):113-31. Soy intake and cancerrisk: a review of the
in vitro and in vivo data. Messina MJ, Persky V, Setchell ...
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer - E Giovannucci, A Ascherio, EB Rimm, MJ Stampfer, … - jnci, 1995 - jnci.oxfordjournals.org ... prostate cancer. Data regarding carotenoids other than -carotene in relation
to prostate cancerrisk are sparse. Purpose: We conducted ...
Migration Patterns and Breast Cancer Risk in Asian-American Women - RG Ziegler, RN Hoover, MC Pike, A Hildesheim, AMY … - jnci, 1993 - jnci.oxfordjournals.org ... Migration Patterns and Breast CancerRisk in Asian-American Women. ... Results: A sixfold
gradient in breast cancerrisk by migration patterns was observed. ...
Hormone replacement therapy and endometrial cancer risk: a meta-analysis - D Grady, T Gebretsadik, K Kerlikowske, V Ernster, … - acogjnl, 1995 - acogjnl.highwire.org ... Hormone replacement therapy and endometrial cancerrisk: a meta-analysis. ... Estrogen
sulfation genes, hormone replacement therapy, and endometrial cancerrisk. ...
Polymorphisms in DNA Repair Genes and Associations with Cancer Risk - EL Goode, CM Ulrich, JD Potter - Cancer Epidemiology Biomarkers & Prevention, 2002 - AACR ... Review. Polymorphisms in DNA Repair Genes and Associations with CancerRisk 1. ...
Polymorphisms in the hMSH2 Gene and the Risk of Primary Lung Cancer. ...
Risk factors for breast cancer in women with proliferative breast disease. - WD Dupont, DL Page - N Engl J Med, 1985 - ncbi.nlm.nih.gov Risk factors for breast cancer in women with proliferative breast disease. ... Calcification
elevated the cancerrisk in patients with proliferative disease. ...
A meta-analysis of previous studies has shown that the statins, cholesterol-lowering medications, do not appear to reduce the incidence of cancer or cancer deaths.
Other studies have suggested that statins reduce the risk of developing cancer.
" Statins have been studied in numerous large-scale, randomized, active- or placebo-controlled trials for primary and secondary prevention of coronary artery disease. In these trials, statins reduced the risk of a first myocardial infarction and overall mortality. With long-term follow-up and collection of cancer data in a majority of studies, insight into the risk of cancer among statin-naïve persons and statin users can be derived," the authors write.
C. Michael White, from the University of Connecticut and Hartford Hospital, and colleagues, conducted a search of the medical literature from 1966 through July 2005 to identify randomized controlled trials of statins.
They found 27 articles ( n = 86,936 participants ) that met their criteria for inclusion, reporting 26 randomized controlled trials of statins with data on either cancer incidence ( n = 20 studies ) or cancer death ( n = 22 studies ).
" In our current meta-analysis, statins did not reduce the incidence of cancer or cancer death," the authors report. " No reductions were noted for cancers of the breast, colon, gastrointestinal tract, prostate, respiratory tract, or melanoma when statins were used." The authors continue, "… the patients in our meta-analysis were primarily treated with simvastatin and pravastatin. As such, we evaluated pravastatin alone and simvastatin alone on cancer incidence and death and found no impact."
" Statins have a neutral effect on cancer and cancer death risks in randomized controlled trials," the authors write in conclusion. " We could find no type of cancer that statins benefited or subtype of statin that reduced the risk of cancer.
Comment by Elizabeth G. Nabel M.D.
